Suchergebnisse - "Ferrucci, Silvia Mariel"

PubPharm (50)

1

Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis : An Italian multicentre study

enthalten in: Contact dermatitis | 2024

von Stingeni, L. | Foti, C. | Guarneri, F. | +26

2

Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?

enthalten in: Journal of clinical medicine | 2024

von Ferrucci, S. | Tavecchio, S. | Ceresa, A. | +4

3

Mental health in patients affected by atopic dermatitis : which effects of treatment with dupilumab?

enthalten in: International clinical psychopharmacology | 2024

von Ferrucci, S. | Tavecchio, S. | Nicolini, G. | +6

4

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors : A case series

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Gori, N. | Ippoliti, E. | Ferrucci, S. | +24

5

Frequency of contact allergy to pentylene glycol. Retrospective cross-sectional study with data from the Società Italiana di Dermatologia Allergologica Professionale e Ambientale (SIDAPA)

enthalten in: Contact dermatitis | 2024

von Gallo, R. | Guarneri, F. | Ferrucci, S. | +12

6

Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis : An Italian Multicenter Analysis

enthalten in: Journal of clinical medicine | 2024

von Pezzolo, E. | Ortoncelli, M. | Ferrucci, S. | +18

7

Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients

enthalten in: Clinical drug investigation | 2024

von Napolitano, M. | Ferrucci, S. | Foggia, L. | +6

8

Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults : A multicentre real-world study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Pezzolo, E. | Schena, D. | Gambardella, A. | +6

9

Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients

enthalten in: Clinical drug investigation | 2023

von Napolitano, M. | Ferrucci, S. | Foggia, L. | +6

10

Correction to : Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

enthalten in: American journal of clinical dermatology | 2023

von Chiricozzi, A. | Ortoncelli, M. | Schena, D. | +22

ErratumFor: Am J Clin Dermatol. 2023 Nov;24(6):953-961. - PMID 37322324

1
2
3
4
5
Nächster »
[5]